← Back to Search

Behavioural Intervention

ABM-01 for Social Anxiety Disorder

N/A

Waitlist Available

Led By Tracy A Dennis-Tiwary, PhD

Research Sponsored by Hunter College of City University of New York

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up bi-weekly time point and at the 6 and 12 month follow-ups

Awards & highlights

Study Summary

This trial is testing a digital therapeutic for social anxiety disorder. Patients will use it for 30 days and be assessed for a range of anxiety and mood symptoms. They will be followed for 6 and 12 months after the study.

Eligible Conditions

Social Anxiety Disorder

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ bi-weekly time point and at the 6 and 12 month follow-ups

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~bi-weekly time point and at the 6 and 12 month follow-ups

This trial's timeline: 3 weeks for screening, Varies for treatment, and bi-weekly time point and at the 6 and 12 month follow-ups for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Secondary outcome measures

Anxiety

Depression, Anxiety, and Stress Scale (DASS-21)

Generalized Anxiety Disorder - 7 (GAD-7)

+4 more

Other outcome measures

Anxiety Sensitivity Index (ASI-3)

Beck Depression Inventory II (BDI-II)

Patient Health Questionnaire (PHQ-2)

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Experimental groupExperimental Treatment1 Intervention

Participants receive active ABM-01 for the study

Group II: Placebo ControlPlacebo Group1 Intervention

Participants receive a digital control for the study

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

ABM-01

2022

N/A

~150

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Wise Therapeutics Inc.UNKNOWN

Hunter College of City University of New YorkLead Sponsor

38 Previous Clinical Trials

8,885 Total Patients Enrolled

Arcade Therapeutics Inc.UNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many subjects are being examined in this research?

"Affirmative. Clinicaltrials.gov reports that this trial is currently recruiting; it was first posted on June 15th 2022 and its most recent update occurred July 8th 2022. This study seeks to recruit 150 individuals across a single site."

Answered by AI

Are individuals under the age of 45 admissible to take part in this trial?

"As per the trial's eligibility requirements, prospective participants must be between 22 and 65 years old."

Answered by AI

What are the eligibility criteria for participating in this research study?

"This medical research accepts patients aged 22-65 diagnosed with Social anxiety Disorder, who are presently residing in the United States and have access to technology that is compatible with the product platform for the duration of this study. A total of 150 participants will be admitted."

Answered by AI

Are there any openings in this trial that can be accessed by participants?

"As per the information shared on clinicaltrials.gov, this research endeavor is presently recruiting participants. This trial was initially advertised on June 15th 2022 and has since been revised on July 8th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Effects of Therapeutic Mobile Game on Anxiety

Tracy Dennis 2022. "Effects of Therapeutic Mobile Game on Anxiety". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05240794.